Purpose of Website
The website www.omerin-usa.com is a showcase/catalogue website accessible via Internet.
Publication
- Company name: OMERIN USA, Inc. QS TECHNOLOGIES
- Address: 95 Research Parkway, Meriden, Connecticut 06450, USA
- Phone. 203-237-2297
- Email: qstech@omerin.com
- Publishing Director: Xavier Omerin
The OMERIN Group team in charge of the project:
- Marketing Manager: Vincent Mathalou (definition, project management, product data management and contents)
- Communication Manager: Henri Huynh (webdesign and contents)
- Digital Marketing Assistant: Sabrinah Uwabera (updates and SEO improvement)
Intellectual Property
All text elements, animated or static images, designs, graphics, instructions for use, templates and all other items used to publish the website www.prince-medical.com are reserved for the exclusive use of OMERIN USA, Inc. QS TECHNOLOGIES or the OMERIN Group. The full or partial reproduction of this site by any means whatsoever without prior authorisation of OMERIN USA, Inc. QS TECHNOLOGIES or the OMERIN Group is prohibited and shall be considered an infringement of copyright and penalised by articles L.335-2 and subsequent of the French intellectual property code.
Names cited on the www.prince-medical.com website and names followed by the ® symbol are registered trademarks or trade names belonging to OMERIN USA, Inc. QS TECHNOLOGIES or the OMERIN Group. The company shall accept no liability resulting from the use of data, information or product ranges provided on this site.
The title, design, form and content of the omerin.com website, such as text, illustrations, original images and their layout, as well as any video compilation, fundamental source code, software (including applets) and other elements of site content are the property of OMERIN USA, Inc. QS TECHNOLOGIES or the OMERIN Group.
The information provided on this site is not contractually binding. All content may be modified without notice and in no event shall it engage the responsibility of OMERIN USA, Inc. QS TECHNOLOGIES or the OMERIN Group and its partners.
Transparency in Coverage
The Transparency in Coverage Rule was issued in 2020 by the U.S. Department of Health & Human Services, U.S. Department of Labor and U.S. Department of the Treasury and enforced beginning 7/1/22, requires health plans (which includes clients who sponsor employee benefit plans) and health insurance issuers to publish two separate MRFs (machine readable files).